Gemmer Asset Management LLC Boosts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Gemmer Asset Management LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 742 shares of the healthcare conglomerate’s stock after buying an additional 40 shares during the period. Gemmer Asset Management LLC’s holdings in UnitedHealth Group were worth $375,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group during the 3rd quarter worth approximately $27,000. Global Wealth Strategies & Associates raised its holdings in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the last quarter. West Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the third quarter valued at $32,000. Quarry LP raised its stake in UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth about $37,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of UNH opened at $510.03 on Tuesday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market cap of $469.37 billion, a price-to-earnings ratio of 32.91, a PEG ratio of 1.39 and a beta of 0.62. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The stock has a 50 day moving average of $549.37 and a 200-day moving average of $563.70.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the company earned $5.83 earnings per share. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.77 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. UnitedHealth Group’s payout ratio is currently 54.19%.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the stock. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, January 15th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research note on Friday, January 10th. UBS Group lowered their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Oppenheimer raised their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, Barclays cut their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday. Two analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.